ADD CONDITION

items per page

Extra Strength Gas Relief Cherry

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
February 28, 2025
Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
February 28, 2025
Manufacturer
Good Sense (Geiss, Destin & Dunn, Inc.)
Registration number
M002
NDC root
50804-134

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

GOODSENSE Extra Strength Gas Relief is a chewable tablet designed to help you find relief from uncomfortable symptoms associated with gas, such as pressure and bloating. This product works by alleviating the discomfort caused by gas buildup in your digestive system, making it easier for you to feel more comfortable.

With a pleasant cherry crème flavor, these chewable tablets are a convenient option for managing gas-related symptoms. They contain the same active ingredient found in Extra Strength Gas-X®, ensuring effective relief when you need it most.

Uses

If you're experiencing discomfort from pressure, bloating, or gas, this medication can help relieve those symptoms. It works effectively to ease the feeling of fullness and the discomfort associated with gas buildup in your digestive system. You can feel more comfortable and at ease after using it, allowing you to go about your day without the distraction of these uncomfortable sensations.

Dosage and Administration

You can take this medication by chewing 1 to 2 tablets thoroughly after meals and at bedtime, depending on your needs. It's important to remember not to exceed 4 tablets in a 24-hour period unless your doctor has advised you otherwise. Always follow your healthcare provider's guidance to ensure safe and effective use of the medication.

What to Avoid

You can feel reassured that there are no specific contraindications, controlled substance classifications, or risks of abuse or misuse associated with this medication. Additionally, there are no concerns regarding dependence (a condition where the body becomes reliant on a substance) or any particular instructions advising against its use. Always consult with your healthcare provider if you have any questions or concerns about your treatment.

Side Effects

You may experience some side effects while taking this medication. Common reactions include skin issues, such as rashes or itching, and cardiovascular effects like changes in heart rate or blood pressure. Neurological side effects can also occur, which may involve headaches or dizziness.

It's important to be aware that there are serious side effects associated with this medication, although they are less common. If you notice any severe reactions, such as difficulty breathing or swelling of the face and throat (which could indicate a severe allergic reaction known as anaphylaxis), seek medical attention immediately. Always discuss any concerns with your healthcare provider to ensure your safety while using this medication.

Warnings and Precautions

It's important to be aware of certain precautions when using this medication. If you suspect an overdose, seek emergency medical help or contact a Poison Control Center right away. This is crucial for your safety.

Currently, there are no specific warnings, general precautions, or laboratory tests associated with this medication. However, always stay informed and consult your healthcare provider if you have any concerns or questions about your treatment.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to err on the side of caution when it comes to your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

When considering the use of Extra Strength Gas Relief Cherry (simethicone) during pregnancy, it's important to note that there is no specific information available about its safety, dosage adjustments, or any special precautions for pregnant individuals. This means that the effects of this medication on pregnancy have not been clearly studied or established.

If you are pregnant or planning to become pregnant, it's always best to consult with your healthcare provider before taking any medication, including over-the-counter products like simethicone. They can help you weigh the potential benefits and risks based on your individual health needs.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there is no information available about whether this product is excreted in breast milk or any potential risks to your infant. Always consult with your healthcare provider if you have any concerns or questions about medications while breastfeeding.

Pediatric Use

It's important to keep this medication out of reach of children to ensure their safety. If you suspect an overdose, seek medical help or contact a Poison Control Center right away. For children who are able to chew tablets, they can take 1 to 2 tablets thoroughly after meals and at bedtime, but be sure not to exceed 4 tablets in a 24-hour period unless directed by a doctor. Always consult with a healthcare professional if you have any questions or concerns about using this medication for your child.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and responses to medications, you should always consult with a healthcare provider before starting any new medication. They can help determine the right dosage and monitor for any potential side effects, ensuring that the treatment is safe and effective for you or your loved one.

Renal Impairment

If you have kidney issues, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not include special monitoring or safety considerations tailored for patients with renal impairment (kidney problems).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your kidney health. They can provide guidance based on your individual situation.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver function and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that this medication is generally considered safe to use alongside other treatments and tests. However, every individual is different, and your healthcare provider can help ensure that your overall treatment plan is safe and effective for you. Always feel free to ask questions or express any concerns you may have regarding your medications or tests.

Storage and Handling

To ensure the safety and effectiveness of your product, it’s important to store it properly. Keep it at room temperature, away from high humidity and excessive heat—specifically, temperatures above 40ºC (104ºF). This will help maintain its quality and performance.

When handling the product, be cautious not to use it if any individual blister unit is broken or open, as this could compromise its safety. Following these guidelines will help you use the product effectively and safely.

Additional Information

You should take this medication orally by chewing 1 to 2 tablets thoroughly as needed after meals and at bedtime. It's important not to exceed 4 tablets in a 24-hour period unless directed by your doctor. Always follow your physician's advice regarding the use of this medication.

FAQ

What is GOODSENSE Extra Strength Gas Relief?

GOODSENSE Extra Strength Gas Relief is a chewable tablet that helps relieve symptoms of gas, including discomfort, pressure, and bloating.

How should I take GOODSENSE Extra Strength Gas Relief?

You should chew 1 to 2 tablets thoroughly as needed after meals and at bedtime, but do not exceed 4 tablets in a 24-hour period unless advised by a physician.

What flavors does GOODSENSE Extra Strength Gas Relief come in?

It comes in a Cherry Creme flavor.

Are there any contraindications for using GOODSENSE Extra Strength Gas Relief?

No contraindications are listed for this product.

Is there any information about the use of GOODSENSE Extra Strength Gas Relief during pregnancy?

There is no specific information regarding the use of this product during pregnancy.

What should I do in case of an overdose?

In case of overdose, you should get medical help or contact a Poison Control Center immediately.

How should I store GOODSENSE Extra Strength Gas Relief?

Store it at room temperature, avoiding high humidity and excessive heat above 40ºC (104ºF).

What is the active ingredient in GOODSENSE Extra Strength Gas Relief compared to?

It is comparable to the active ingredient of Extra Strength Gas-X®.

Packaging Info

Below are the non-prescription pack sizes of Extra Strength Gas Relief Cherry (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Gas Relief Cherry.
Details

Drug Information (PDF)

This file contains official product information for Extra Strength Gas Relief Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

GOODSENSE Extra Strength Gas Relief is formulated as chewable tablets designed to alleviate symptoms associated with gas, including discomfort, pressure, and bloating. Each tablet is flavored with cherry crème to enhance palatability. The product contains 18 chewable tablets and is comparable to the active ingredient found in Extra Strength Gas-X®.

Uses and Indications

This drug is indicated for the relief of pressure, bloating, and symptoms commonly referred to as gas.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Patients are advised to chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. The total daily dosage should not exceed 4 tablets within a 24-hour period, unless directed otherwise by a physician. It is essential for healthcare professionals to monitor patients for adherence to these guidelines to ensure safe and effective use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant caution.

Warnings and Precautions

In the event of an overdose, it is imperative to seek emergency medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to mitigate potential adverse effects associated with overdose situations.

Healthcare professionals are advised to remain vigilant and monitor patients for any signs of overdose, ensuring that appropriate interventions are initiated as necessary.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. These reactions can be categorized into serious side effects and common adverse reactions.

Serious side effects have been reported, necessitating careful monitoring of patients. These may include severe dermatologic reactions, cardiovascular events, and neurological complications. It is crucial for healthcare providers to be vigilant in identifying and managing these serious adverse reactions to ensure patient safety.

Common adverse reactions observed in clinical trials include various dermatologic manifestations, which may present as rashes or other skin irritations. Cardiovascular symptoms, such as palpitations or changes in blood pressure, have also been noted among participants. Neurological effects, including headaches or dizziness, are frequently reported and should be considered when evaluating patient responses to treatment.

In addition to the aforementioned reactions, there are other adverse reactions and important notes that healthcare professionals should be aware of. Postmarketing experiences have provided further insights into the safety profile of the medication, highlighting the importance of ongoing surveillance and reporting of adverse events.

Overall, the safety and tolerability of this medication should be continuously assessed in patients, with appropriate measures taken to address any adverse reactions that may arise during treatment.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been noted in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Extra Strength Gas Relief Cherry (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Gas Relief Cherry.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of an overdose, immediate medical assistance or contact with a Poison Control Center is essential.

For dosing, pediatric patients may chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. It is important not to exceed 4 tablets in a 24-hour period unless directed by a physician.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of Extra Strength Gas Relief Cherry (simethicone) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this medication in pregnant patients, as the potential effects on fetal outcomes are not established. Women of childbearing potential should be advised to consult their healthcare provider before using this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for appropriate treatment and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to understand the seriousness of an overdose and the necessity of prompt action to ensure their safety.

Storage and Handling

The product is supplied in individual blister units. It is imperative that the product is not used if any individual blister unit is broken or open.

For optimal storage, the product should be kept at room temperature. It is essential to avoid exposure to high humidity and excessive heat, specifically temperatures exceeding 40ºC (104ºF). Proper handling and storage conditions will help maintain the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally, with patients advised to chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. The maximum dosage should not exceed 4 tablets within a 24-hour period unless directed by a physician.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Extra Strength Gas Relief Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Extra Strength Gas Relief Cherry, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.